Heather Pratt-Chavez

Professor with a passion for advancing studies in neonatal care, Dr. Heather Pratt-Chavez serves as an Associate Professor of General Pediatrics at the University of New Mexico. Her work is centered on the care of neonates with prenatal drug exposure, a field where she has made significant contributions through both her clinical practice and academic endeavors. Dr. Pratt-Chavez is dedicated to the compassionate care of this highly vulnerable and often marginalized population, understanding the complex challenges faced by both the infants and their mothers. Dr. Pratt-Chavez's approach is holistic, emphasizing not only the medical needs of these neonates but also the social and emotional support required by their families. Her commitment to providing excellent medical care is matched by her dedication to educating the community about the issues surrounding prenatal drug exposure. She actively engages in outreach programs aimed at raising awareness and fostering a supportive environment for affected families. In addition to her clinical and educational roles, Dr. Pratt-Chavez is deeply involved in advancing scholarship in her field. She has contributed to numerous publications and presentations, sharing her insights and research findings with the broader medical community. Her work is characterized by a focus on evidence-based practices and innovative approaches to care. Dr. Pratt-Chavez aspires to continue her leadership role in compassionate care for this vulnerable population. She is committed to mentoring the next generation of healthcare professionals, instilling in them the values of empathy, understanding, and excellence in medical practice. Her vision is to create a healthcare system that is inclusive and responsive to the needs of all patients, particularly those who are most at risk. Through her dedication and expertise, Dr. Pratt-Chavez has become a respected figure in the field of pediatrics. Her contributions have not only improved the lives of countless neonates and their families but have also paved the way for future advancements in the care of children with prenatal drug exposure.